Paper92563
Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.
Read GW and 1 other. J Pharmacol Exp Ther, 1979. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines. Papers, record 92563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/92563
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzalkonium Compounds | Major topic |
| Histamine Release | Major topic |
| Polyamines | Major topic |
| p-Methoxy-N-methylphenethylamine | Major topic |
| Animals | |
| Female | |
| Male | |
| Mast Cells | |
| Polyethylene Glycols | |
| Rats | |
| Type C Phospholipases |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,815,634 | Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase. | J Immunotoxicol | 2024 | https://conductscience.org/library/papers/39815634 | PubMed |
| 36,211,198 | Quaternary ammonium compounds in hypersensitivity reactions. | Front Toxicol | 2022 | https://conductscience.org/library/papers/36211198 | PubMed |
| 28,377,880 | Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC. | Respir Med Case Rep | 2017 | https://conductscience.org/library/papers/28377880 | PubMed |
| 24,812,509 | Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery. | Int J Nanomedicine | 2014 | https://conductscience.org/library/papers/24812509 | PubMed |
| 18,309,682 | Benzalkonium chloride induced bronchoconstriction in patients with stable bronchial asthma. | Korean J Intern Med | 2007 | https://conductscience.org/library/papers/18309682 | PubMed |
| 15,082,905 | Anaphylaxis caused by benzalkonium in a nebulizer solution. | J Korean Med Sci | 2004 | https://conductscience.org/library/papers/15082905 | PubMed |
| 8,713,487 | Adverse drug events related to dosage forms and delivery systems. | Drug Saf | 1996 | https://conductscience.org/library/papers/8713487 | PubMed |
| 8,027,189 | G-protein ligands inhibit in vitro reactions of vacuole inheritance. | J Cell Biol | 1994 | https://conductscience.org/library/papers/8027189 | PubMed |
| 7,643,958 | Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. | Neurochem Res | 1995 | https://conductscience.org/library/papers/7643958 | PubMed |
| 7,326,027 | Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen. | Biochem J | 1981 | https://conductscience.org/library/papers/7326027 | PubMed |
| 6,209,203 | On disturbance of homeostasis in organ-cultured tissue. | In Vitro | 1984 | https://conductscience.org/library/papers/6209203 | PubMed |
| 6,203,369 | Mechanism of histamine release from rat isolated peritoneal mast cells by dextran: the role of immunoglobulin E. | Agents Actions | 1984 | https://conductscience.org/library/papers/6203369 | PubMed |
| 6,177,220 | Species and tissue differences of histamine storage and release. | Agents Actions | 1982 | https://conductscience.org/library/papers/6177220 | PubMed |
| 3,041,246 | Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II). | Med Toxicol Adverse Drug Exp | 1988 | https://conductscience.org/library/papers/3041246 | PubMed |
| 2,972,308 | The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2972308 | PubMed |
| 2,954,609 | Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. | Br Med J (Clin Res Ed) | 1987 | https://conductscience.org/library/papers/2954609 | PubMed |
| 2,477,717 | Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells. | Naunyn Schmiedebergs Arch Pharmacol | 1989 | https://conductscience.org/library/papers/2477717 | PubMed |
| 2,469,022 | Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80. | Naunyn Schmiedebergs Arch Pharmacol | 1988 | https://conductscience.org/library/papers/2469022 | PubMed |
| 2,451,929 | The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2451929 | PubMed |
| 2,440,265 | Action of the SP2-11 and SP3-11 fragments of substance P on rat peritoneal mast cells. | Agents Actions | 1987 | https://conductscience.org/library/papers/2440265 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/92563
GET https://conductscience.org/api/papers/v1/92563/cited_by?page=2